Related references
Note: Only part of the references are listed.The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 Diabetes The DCCT/EDIC Trials
Matthew Budoff et al.
JACC-CARDIOVASCULAR IMAGING (2019)
The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review
Sarah Louise Fishman et al.
MOLECULAR MEDICINE (2018)
Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and nondiabetic populations: a systematic review and meta-analysis
Ivan Cavero-Redondo et al.
BMJ OPEN (2017)
Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis
Bin Li et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Noninvasive Cardiovascular Risk Assessment of the Asymptomatic Diabetic Patient The Imaging Council of the American College of Cardiology
Matthew J. Budoff et al.
JACC-CARDIOVASCULAR IMAGING (2016)
Glycosylated Hemoglobin in Relationship to Cardiovascular Outcomes and Death in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Yurong Zhang et al.
PLOS ONE (2012)
Insulin Resistance, Hyperglycemia, and Atherosclerosis
Karin E. Bornfeldt et al.
CELL METABOLISM (2011)
Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009
R. A. DeFronzo
DIABETOLOGIA (2010)
Innate immunity, macrophage activation, and atherosclerosis
Zhong-qun Yan et al.
IMMUNOLOGICAL REVIEWS (2007)
Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals
Merri Pendergrass et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Molecular understanding of hyperglycemia's adverse effects for diabetic complications
MJ Sheetz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
